Skip to main content

Table 3 Multivariate logistic regression analysis for outcome

From: Administration of recombinant thrombomodulin before progression of disease causing disseminated intravascular coagulation might be better compared with administration after progression of disease

  Reference Adjusted odds ratio 95% confidence interval pvalue
Gender Female 3.39 1.19–9.64 0.022
APACHEII at start of rTM - 1.18 1.09–1.29 <0.001
rTM 1 day 0 days 1.95 0.57–6.62 0.29
rTM 2 days 0 days 3.36 1.03–10.92 0.044
  1. Hosmer-Lemeshow test (chi-square = 15.13, degrees of freedom = 8, p = 0.057).
  2. C-statistics = 0.82.
  3. APACHEII Acute Physiology and Chronic Health Evaluation II, rTM recombinant thrombomodulin. rTM x day Duration from the onset of disease to rTM administration was x day, 2- days more than 2 days.